Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Type I Diabetes I: Introduction

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Biosynthesis and bioactivity of anti-inflammatory triterpenoids in Calendula officinalis.

Nature communications·2025

Same author

Neoadjuvant radiochemotherapy in patients with high-risk locally advanced cervical cancer-results of a clinical series.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2025

Same author

Modulation of Nrf2 expression by targeting i-motif DNA.

Communications chemistry·2025

Same author

The influence of neonatal BCG vaccination on in vitro cytokine responses to Plasmodium falciparum.

BMC immunology·2024

Same author

Investigating the efficacy of baricitinib in new onset type 1 diabetes mellitus (BANDIT)-study protocol for a phase 2, randomized, placebo controlled trial.

Trials·2022

Same author

Reconsidering fear of birth: Language matters.

Midwifery·2021

Search research articles

Related Experiment Video

Updated: Jul 14, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

Major increase in Type 1 diabetes: no support for the Accelerator Hypothesis.

M A O'Connell¹, S Donath, F J Cameron

¹Department of Endocrinology and Diabetes, Royal Children's Hospital and Murdoch Children's Research Institute, Melbourne, Australia.

Diabetic Medicine : a Journal of the British Diabetic Association

|May 31, 2007

Summary

This study found no evidence that increased body mass accelerates Type 1 diabetes mellitus (T1DM) onset, despite a rise in T1DM diagnoses. Our findings do not support the Accelerator Hypothesis for T1DM presentation.

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Related Experiment Videos

Last Updated: Jul 14, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Area of Science:

Pediatrics
Endocrinology
Metabolic Disorders

Background:

The Accelerator Hypothesis suggests weight-related insulin resistance accelerates Type 1 diabetes mellitus (T1DM) onset.
A recent increase in T1DM diagnoses was observed, prompting investigation into the hypothesis.
The hypothesis predicts younger age and higher BMI at diagnosis, with the youngest children having the highest BMI.

Purpose of the Study:

To evaluate the Accelerator Hypothesis in relation to a significant rise in T1DM diagnoses at our center.
To determine if increased body mass is associated with earlier T1DM presentation.

Main Methods:

Retrospective review of T1DM diagnoses in young individuals from 1992-2003.
Calculation of Body Mass Index (BMI) from height and weight measurements at initial diagnosis.

Main Results:

While BMI standard deviation score (SDS) and age at diagnosis increased annually, no association was found between BMI SDS and age.
A significant difference in BMI SDS was observed across age groups, but youngest children had the lowest BMI SDS.
The study did not find that increased body mass accelerates diabetes presentation.

Conclusions:

The findings do not support the Accelerator Hypothesis regarding increased body mass as a factor in T1DM presentation.
The observed increase in T1DM diagnoses is not explained by accelerated onset due to weight-related insulin resistance.
Further research is needed to understand the factors driving the rise in T1DM incidence.